Doug Nesta, Ph.D.

Particle Analysis as a Formulation Development Tool
Thursday, September 01, 2011
The need to detect, monitor, and characterize particulates in parenteral products has become one of the most noteworthy trends in the biopharmaceutical industry. The level of aggregates and particulates is a critical quality ... read more
Biophysical Approaches to the Detection and Characterization of Particles in an Antibody Solution
Tuesday, December 01, 2009
Monoclonal antibodies (mAbs) can express their inherent physical instability by following one of several degradation pathways: adsorption, denaturation, or aggregation [1,2]. read more

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary
print or digital subscription

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.